NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic

NIH-Funded Scientists Create Potential Long-Acting HIV Therapeutic

NIAID-Funded Scientists Create Potential Long-Acting HIV Therapeutic

New Molecule also Might Prevent HIV Infection

Scientists have created a new molecule that shows promise for controlling HIV without daily antiretroviral drugs. The molecule foils a wider range of HIV strains in the laboratory than any known broadly neutralizing HIV antibody and is more powerful than some of the most potent of these antibodies. In addition, the molecule safely protected monkeys from infection with an HIV-like virus during a 40-week study period. Together, the data suggest that the molecule could, with further research, be used to subdue HIV in humans.